Feature
Video
Sponsored Video
Author(s):
Benedikt von Braunmühl, CEO of Rentschler Biopharma, discusses the company's strategic shift toward biologics CDMO services.
Rentschler Biopharma is pivoting to biologics CDMO services to better align with evolving market demand. Watch this video to learn more about:
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
2 Commerce Drive
Cranbury, NJ 08512